Trial of New Pretreatment Method in Transnasal Endoscopy
NCT ID: NCT01708967
Last Updated: 2014-03-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2009-03-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* "Catheter-free method"
* "Catheter-insertion method"
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Topical and Nebulized Anesthesia in Patients Undergoing Esophago-Gastro-Duodenoscopy
NCT02317770
Lidocaine Spray vs Viscous Lidocaine Solution Plus Lidocaine Spray in Patients Undergoing Non-Sedated EGD
NCT06185933
Intranasal Lidocaine Spray Versus Nasogastric Tube Administration in the Emergency Room
NCT07103915
Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy
NCT02733471
Topical Oral Anesthesia Adjuncts in Conventional Intubation on First-Pass Success Rate
NCT06661967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. underlying systemic disease
2. drug allergy
3. anticoagulant or antiplatelet use
2. Premedication (both method)
1. taking premedication contain dimethylpolysiloxane, pronase, sodium bicarbonate for improved endoscopic visualization
2. spraying naphazolin acetate into nasal cavity for decrease secretion
3. Different anesthetic method for transnasal endoscopy
1. "Catheter-free method" : spraying epinephrine into nasal cavity
2. "Catheter-insertion method" : spraying both epinephrine and lidocaine into nasal cavity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Catheter-free method
We explored success rate, side effects, and vital signs in patients with catether-free method.
Intervention: one-time spray of epinephrine (1cc) plus 4% lidocaine (4cc)
pretreatment method for transnasal endoscopy
Catheter-free method : The patient then takes simethicone (10cc). After that, the nasal cavity is sprayed with epinephrine (1cc) and lidocaine HCL (4%, 4cc).
Catheter inesertion method: After preparation steps the same as in the 'catheter-free' method, a 14 Fr. flexible catheter is coated with 2% lidocaine HCL gel and 8% lidocaine HCL spray. After that, the catheter is inserted into the patient's nasal cavity, and maintained about 1 minute for anesthesia. A 16 Fr. catheter is prepared by the same method with as the 14Fr. catheter. After the 14 Fr. cathter has been removed from the patient's nasal cavity, the 16 Fr. catheter is inserted into the patient's nasal cavity.
Catheter insertion method
We explored success rate, side effects, and vital signs in patients with catether insertion method : use both spray and catheter
pretreatment method for transnasal endoscopy
Catheter-free method : The patient then takes simethicone (10cc). After that, the nasal cavity is sprayed with epinephrine (1cc) and lidocaine HCL (4%, 4cc).
Catheter inesertion method: After preparation steps the same as in the 'catheter-free' method, a 14 Fr. flexible catheter is coated with 2% lidocaine HCL gel and 8% lidocaine HCL spray. After that, the catheter is inserted into the patient's nasal cavity, and maintained about 1 minute for anesthesia. A 16 Fr. catheter is prepared by the same method with as the 14Fr. catheter. After the 14 Fr. cathter has been removed from the patient's nasal cavity, the 16 Fr. catheter is inserted into the patient's nasal cavity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pretreatment method for transnasal endoscopy
Catheter-free method : The patient then takes simethicone (10cc). After that, the nasal cavity is sprayed with epinephrine (1cc) and lidocaine HCL (4%, 4cc).
Catheter inesertion method: After preparation steps the same as in the 'catheter-free' method, a 14 Fr. flexible catheter is coated with 2% lidocaine HCL gel and 8% lidocaine HCL spray. After that, the catheter is inserted into the patient's nasal cavity, and maintained about 1 minute for anesthesia. A 16 Fr. catheter is prepared by the same method with as the 14Fr. catheter. After the 14 Fr. cathter has been removed from the patient's nasal cavity, the 16 Fr. catheter is inserted into the patient's nasal cavity.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chuncheon Sacred Heart Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ki Tae Suk
doctor, assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ki Tae Suk, M.D.,Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OTSMVSSCM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.